Bradley Merrill Thompson, Member of the Firm, will copresent on regulatory and legal oversight at the Institute of Medicine's Refining Processes for the Co-Development of Genome-Based Therapeutics and Companion Diagnostic Tests: A Workshop.
For more information, visit IOM.edu.